Blockbuster deal

NBR_SOCIAL_MEDIA_PROMO bio

Inside Pfizer’s $100 billion blockbuster offer for AstraZeneca. Is a more favorable tax rate in Britain the real reason behind the deal?

For this story and more tune in tonight.

This entry was posted in Health Care, M&A. Bookmark the permalink.

Leave a Reply